Torus Ventures v. Superior Healthplan: Voluntary Dismissal in 28 Days
Torus Ventures LLC asserted US7203844B1 — a method and system for recursive security and digital copyright control — against health plan provider Superior Healthplan Inc. in the Eastern District of Texas. The case ended in voluntary dismissal without prejudice just 28 days after filing, before the defendant had answered.
Digital copyright patent suit exits E.D. Texas before defendant responds
On 5 February 2025, Torus Ventures LLC filed a patent infringement action in the Eastern District of Texas before Judge Rodney Gilstrap, asserting US7203844B1 against Superior Healthplan Inc. The patent — directed to a recursive security protocol for digital copyright control — was applied against the defendant’s systems or services, though the specific accused product details remain limited in the public record. The Eastern District of Texas is a historically active patent venue and Judge Gilstrap one of its most experienced patent jurists.
On 5 March 2025 — just 28 days after filing — Torus Ventures filed a Notice of Voluntary Dismissal Without Prejudice pursuant to Federal Rule of Civil Procedure 41(a)(1)(A)(i). Because Superior Healthplan had not yet answered the complaint or moved for summary judgment, the dismissal was available as of right. Judge Gilstrap accepted and acknowledged the dismissal, ordering all claims dismissed without prejudice and each party to bear its own costs, expenses, and attorneys’ fees.
A 28-day lifecycle is exceptionally short even for cases that settle or are dropped, suggesting the decision to dismiss was made very shortly after filing — possibly prompted by early communication between the parties, a licensing discussion, or a strategic reassessment by plaintiff’s counsel. The without-prejudice designation means Torus Ventures retains the legal right to refile substantially similar claims, making the resolution notable for its lack of finality. The public record does not disclose whether any commercial or licensing arrangement was reached.
Filing to Voluntary dismissal in 28 days
Closed in 28 days — well below the district median for patent cases
Voluntarily dismissed: what the Rule 41 exit means for both parties
Rule 41(a)(1)(A)(i): dismissal as of right, no court permission needed
Federal Rule of Civil Procedure 41(a)(1)(A)(i) permits a plaintiff to dismiss an action without a court order — and without prejudice — provided the defendant has not yet served an answer or a motion for summary judgment. Superior Healthplan had not done either, so Torus Ventures exercised this right unilaterally. The court’s role was limited to accepting and acknowledging the notice, not approving or conditioning it.
Plaintiff’s unilateral rightWithout prejudice: the case ends, but the door stays open
A dismissal without prejudice does not adjudicate the merits and does not bar Torus Ventures from refiling the same infringement claims against Superior Healthplan in the future, subject to any applicable statute of limitations. A dismissal with prejudice would permanently foreclose those claims. The public record here is silent on whether any commercial resolution — such as a licence — accompanied the dismissal, which is typical for cases of this nature.
Refiling remains possibleSuperior Healthplan exits without an adverse finding — for now
Superior Healthplan avoids any finding of infringement and bears no court-ordered damages or costs. The without-prejudice designation means the threat is not permanently retired: Torus Ventures could refile if circumstances change — for example, if licensing negotiations break down or a new counsel strategy emerges. Each party bearing its own fees also means Superior Healthplan recovers none of its defence costs.
No merits adjudicationEach party bears its own fees — no fee-shifting awarded
The court’s order that each party bear its own costs, expenses, and attorneys’ fees is standard for Rule 41(a) voluntary dismissals and does not reflect any finding of exceptional case status under 35 U.S.C. § 285. Had the case proceeded to a defence verdict, Superior Healthplan might have sought fee recovery. The brevity of the case — 28 days — means accrued litigation costs on both sides were likely modest relative to a typical patent dispute.
No § 285 fee awardFull party and counsel information
| Role | Name | Type | Detail |
|---|---|---|---|
| Plaintiff | Torus Ventures, LLC | Company | Patent assertion entity — holder of US7203844B1, a digital copyright control patentSearch in Eureka ↗ |
| Defendant | Superior Healthplan, Inc. | Company | Superior Healthplan Inc. — managed care health plan provider operating in TexasSearch in Eureka ↗ |
| Plaintiff counsel | Isaac Phillip Rabicoff | Attorney | Counsel for Torus Ventures, LLCSearch in Eureka ↗ |
| Plaintiff law firm | Rabicoff Law LLC | Law Firm | Representing Torus Ventures, LLCSearch in Eureka ↗ |
| Presiding judge | Judge Rodney Gilstrap | Judge | Texas Eastern District CourtSearch in Eureka ↗ |
Official order — verbatim text
The court’s order accepts and acknowledges the Rule 41(a)(1)(A)(i) dismissal without exercising independent discretion — the plain language ‘ACCEPTS AND ACKNOWLEDGES’ reflects the ministerial nature of the ruling when a plaintiff dismisses as of right. The phrase ‘DISMISSED WITHOUT PREJUDICE’ is controlling: no claim has been adjudicated on the merits, preserving Torus Ventures’ future enforcement options. The denial of all other pending relief as moot is procedurally standard and carries no substantive significance for either party.
US7203844B1 — Recursive security protocol for digital copyright control
US7203844B1 (application number US10/465274) covers a method and system implementing a recursive security protocol designed to manage digital copyright control. Recursive security architectures are associated with layered, hierarchical rights management — systems that verify permissions at multiple nested levels before granting access or enabling use of protected digital content. The patent’s B1 designation indicates it issued without any post-grant amendment, suggesting the claims as issued reflect the original prosecution scope.
The assertion of a digital copyright control patent against a managed care health plan is commercially notable: it suggests plaintiff counsel may be reading the claims to cover digital rights or access-control mechanisms used in healthcare data systems, member portals, or content delivery infrastructure. Any organisation deploying layered authentication, digital rights management, or hierarchical access control in healthcare IT — or adjacent sectors — should evaluate whether US7203844B1 or its related family poses a litigation risk, particularly given the without-prejudice dismissal leaves the door open for refiling.
Should you run an FTO analysis against US7203844B1?
If your organisation develops, licenses, or deploys digital rights management, recursive access control, or copyright protection systems — particularly in healthcare IT, SaaS, or content delivery — US7203844B1 warrants a formal freedom-to-operate review. The without-prejudice dismissal in this case means the patent remains fully enforceable and active; Torus Ventures retains the right to assert it against Superior Healthplan or any other party at any time within the limitations period.
PatSnap Eureka’s FTO Search Agent can map the claim language of US7203844B1 against your product architecture, identify prior art that may support an invalidity argument, and surface any continuation or divisional applications in the same family that could pose separate infringement risks. Early-stage FTO analysis is significantly cheaper than litigation defence — especially in the Eastern District of Texas, where discovery costs alone can run into seven figures.
Run a freedom-to-operate analysis on US7203844B1 to assess your product’s exposure
Run FTO in Eureka →Similar digital copyright and recursive security patent cases in E.D. Texas
Cases involving digital rights management and security protocol patents before Judge Gilstrap in the Eastern District of Texas — including comparable NPE assertion patterns.
What this case signals for the digital copyright enforcement IP landscape
A rapid voluntary dismissal in E.D. Texas without prejudice carries distinct strategic implications for both targets and holders of digital security patents.
E.D. Texas remains a preferred venue for digital-technology patent assertions
Torus Ventures’ choice of the Eastern District of Texas and Judge Gilstrap is consistent with the district’s continued attractiveness for patent plaintiffs — particularly NPEs asserting software-adjacent patents. Companies with technology touching digital security or copyright control should monitor filings in this jurisdiction closely.
Without-prejudice exits warrant ongoing patent monitoring, not celebration
Superior Healthplan’s exit without prejudice is a tactical reprieve, not a legal victory. Organisations targeted by without-prejudice dismissals should conduct a thorough freedom-to-operate review of the asserted patent and any related family members to assess residual risk before the matter resurfaces.
Torus v Superior — key questions answered
Torus Ventures LLC voluntarily dismissed its patent infringement action against Superior Healthplan Inc. without prejudice on 5 March 2025, just 28 days after filing. The case was dismissed under Rule 41(a)(1)(A)(i) before Superior Healthplan answered, with each party bearing its own costs. No merits determination was made.
A voluntary dismissal without prejudice means the case ends without any finding of infringement, liability, or invalidity. However, the plaintiff retains the right to refile substantially the same claims against the same defendant in the future, subject to the applicable statute of limitations. Superior Healthplan received no fee recovery and faces continued theoretical exposure under US7203844B1.
The patent asserted was US7203844B1, applied for under application number US10/465274. It covers a method and system for a recursive security protocol for digital copyright control. The patent was asserted against Superior Healthplan’s systems, though the specific accused functionality is not detailed in the public court record.
A 28-day dismissal before the defendant answers is consistent with several scenarios: early licensing or settlement discussions that made litigation unnecessary, a strategic reassessment of claim strength against the specific defendant’s products, or a plaintiff’s use of litigation filing as leverage for out-of-court resolution. The public record in this case does not disclose the specific reason.
Yes. A voluntary dismissal without prejudice has no effect on the validity or enforceability of US7203844B1. The patent remains in force and Torus Ventures retains all enforcement rights. Companies in digital rights management, healthcare IT access control, or related sectors should treat the patent as an active risk and consider an FTO review.
PatSnap Eureka searches patents and litigation data to answer instantly.